Congestive Heart Failure: NYHA functional class II https://greenmedinfo.com/taxonomy/term/71852/all en At therapeutic doses, hawthorn may cause a variety of side effects, but limited data suggest that it may be useful in the treatment of NYHA functional class II congestive heart failure. https://greenmedinfo.com/article/therapeutic-doses-hawthorn-may-cause-variety-side-effects-limited-data-suggest PMID:  Am J Health Syst Pharm. 2002 Mar 1 ;59(5):417-22. PMID: 11887407 Abstract Title:  Hawthorn: pharmacology and therapeutic uses. Abstract:  The uses, pharmacology, clinical efficacy, dosage and administration, adverse effects, and drug interactions of hawthorn are discussed. Hawthorn (Crataegus oxyacantha) is a fruit-bearing shrub with a long history as a medicinal substance. Uses have included the treatment of digestive ailments, dyspnea, kidney stones, and cardiovascular disorders. Today, hawthorn is used primarily for various cardiovascular conditions. The cardiovascular effects are believed to be the result of positive inotropic activity, ability to increase the integrity of the blood vessel wall and improve coronary blood flow, and positive effects on oxygen utilization. Flavonoids are postulated to account for these effects. Hawthorn has shown promise in the treatment of New York Heart Association (NYHA) functional class II congestive heart failure (CHF) in both uncontrolled and controlled clinical trials. There are also suggestions of a beneficial effect on blood lipids. Trials to establish an antiarrhythmic effect in humans have not been conducted. The recommended daily dose of hawthorn is 160-900 mg of a native water-ethanol extract of the leaves or flowers (equivalent to 30-169 mg of epicatechin or 3.5-19.8 mg of flavonoids) administered in two or three doses. At therapeutic dosages, hawthorn may cause a mild rash, headache, sweating, dizziness, palpitations, sleepiness, agitation, and gastrointestinal symptoms. Hawthorn may interact with vasodilating medications and may potentiate or inhibit the actions of drugs used for heart failure, hypertension, angina, and arrhythmias. The limited data about hawthorn suggest that it may be useful in the treatment of NYHA functional class II CHF. https://greenmedinfo.com/article/therapeutic-doses-hawthorn-may-cause-variety-side-effects-limited-data-suggest#comments Congestive Heart Failure Congestive Heart Failure: NYHA functional class II Hawthorn Cardioprotective Phytotherapy Review Thu, 10 May 2012 00:13:09 +0000 greenmedinfo 75464 at https://greenmedinfo.com Dance therapy may improve peak VO2 and HRQOL in patients with chronic heart failure . https://greenmedinfo.com/article/dance-therapy-may-improve-peak-vo2-and-hrqol-patients-chronic-heart-failure PMID:  Clin Rehabil. 2014 May 21. Epub 2014 May 21. PMID: 24849796 Abstract Title:  Dance therapy in patients with chronic heart failure: a systematic review and a meta-analysis. Abstract:  OBJECTIVE: To see whether dance therapy was more effective than conventional exercise in exercise capacity and health-related quality of life (HRQOL) in patients with chronic heart failure.DESIGN AND METHODS: Systematic review and meta-analysis. We searched MEDLINE, Cochrane Controlled Trials Register, EMBASE, SPORT Scielo, CINAHL (from the earliest date available to August 2013) for randomized controlled trials (RCTs), examining effects of dance therapy versus exercise and/or dance therapy versus control on exercise capacity (VO2peak), and quality-of-life (QOL) in chronic heart failure. Two reviewers selected studies independently. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I(2) test.RESULTS: Two studies met the study criteria (62 dance therapy patients, 60 exercise patients and 61 controls patients). The results suggested that dance therapy compared with control had a positive impact on peak VO2 and HRQOL. Dance therapy resulted in improvement in: peak VO2 peak weighted mean difference (4.86 95% CI: 2.81 to 6.91) and global HRQOL standardized mean differences (2.09 95% CI: 1.65 to 2.54). Non-significant difference in VO2 peak and HRQOL for participants in the exercise group compared with dance therapy. No serious adverse events were reported.CONCLUSIONS: Dance therapy may improve peak VO2 and HRQOL in patients with chronic heart failure (CHF) and could be considered for inclusion in cardiac rehabilitation programmes. https://greenmedinfo.com/article/dance-therapy-may-improve-peak-vo2-and-hrqol-patients-chronic-heart-failure#comments Congestive Heart Failure: NYHA functional class II Heart Failure Cardioprotective Cardiotonic Agents Dancing Meta Analysis Sat, 18 Oct 2014 20:38:01 +0000 greenmedinfo 115033 at https://greenmedinfo.com How Yoga Heals The Diseased Heart https://greenmedinfo.com/blog/how-yoga-heals-diseased-heart-1 <div class="copyright">This article is copyrighted by GreenMedInfo LLC, 2015<br/><strong><a href="/greenmedinfocom-re-post-guidelines">Visit our Re-post guidelines</a></strong></div><p class="rtecenter" dir="ltr"><img alt="How Yoga Heals The Diseased Heart" src="//cdn.greenmedinfo.com/sites/default/files/ckeditor/Sayer Ji/images/Yogahands.jpg" style="height: 400px; width: 600px" title="How Yoga Heals The Diseased Heart" /></p> <h2 dir="ltr"> <em><span style="font-size: 18px"><strong>What if the simple act of doing yoga could heal your diseased heart?&nbsp;</strong></span></em></h2> <p dir="ltr">A new study titled, "<strong><a href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S0066-782X2014005040149&amp;lng=en&amp;nrm=iso&amp;tlng=en" target="_blank">Effects of Yoga in Patients with Chronic Heart Failure: A Meta-Analysis</a></strong>," reveals that this ancient practice, ever-increasing in popularity in the West, has profound benefits to those who are <strong><a href="/disease/cardiovascular-diseases" target="_blank">suffering from cardiovascular disease</a></strong>.</p><p><a href="https://greenmedinfo.com/blog/how-yoga-heals-diseased-heart-1" target="_blank">read more</a></p> https://greenmedinfo.com/blog/how-yoga-heals-diseased-heart-1#comments Cardiovascular Disease Congestive Heart Failure Congestive Heart Failure: NYHA functional class II Heart Attack Heart Attack: Recovery Heart Failure Cardioprotective Cardiotonic Agents Therapeutic Breathing Yoga Diseased Heart Healing a Diseased Heart Healing Yoga How Yoga Heals Mon, 20 Oct 2014 03:06:41 +0000 Sayer Ji 115065 at https://greenmedinfo.com Yoga has a positive effect on patients witih chronic heart failure. https://greenmedinfo.com/article/yoga-has-positive-effect-patients-witih-chronic-heart-failure PMID:  Arq Bras Cardiol. 2014 Oct 10 ;0. Epub 2014 Oct 10. PMID: 25317861 Abstract Title:  Effects of Yoga in Patients with Chronic Heart Failure: A Meta-Analysis. Abstract:  The use of yoga as an effective cardiac rehabilitation in patients with chronic heart failure (CHF) remains controversial. We performed a meta-analysis to examine the effects of yoga on exercise capacity and health-related quality of life (HRQOL) in patients with CHF. Methods: We searched MEDLINE, Cochrane Central Register of Controlled Trials, Excerpta Medica database, LILACS, Physiotherapy Evidence Database, The Scientific Electronic Library Online, and Cumulative Index to Nursing and Allied Health (from the earliest date available to December 2013) for randomized controlled trials (RCTs) examining the effects of yoga versus exercise and/or of yoga versus control on exercise capacity (peakVO2) and quality-of-life (HRQOL) in CHF. Two reviewers selected studies independently. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) were calculated, and heterogeneity was assessed using the I2 test. Two studies met the selection criteria (total: 30 yoga and 29 control patients). The results suggested that yoga compared with control had a positive impact on peak VO2 and HRQOL. Peak VO2, WMD (3.87 95% CI: 1.95 to 5.80), and global HRQOL standardized mean differences (-12.46 95% CI: -22.49 to -2.43) improved in the yoga group compared to the control group. Yoga enhances peak VO2 and HRQOL in patients with CHF and could be considered for inclusion in cardiac rehabilitation programs. Larger RCTs are required to further investigate the effects of yoga in patients with CHF. https://greenmedinfo.com/article/yoga-has-positive-effect-patients-witih-chronic-heart-failure#comments Congestive Heart Failure Congestive Heart Failure: NYHA functional class II Heart Failure Cardioprotective Cardiotonic Agents Yoga Meta Analysis Sat, 18 Oct 2014 20:36:53 +0000 greenmedinfo 115032 at https://greenmedinfo.com